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The metabolism of 20:4 (arachidonic acid) in alkenylacyl, alkylacyl and diacyl lipid classes in choline 
glycerophospholipids (CGP) and ethanolamine glycerophospholipids (EGP) in rabbit alveolar 
macrophages was examined. [‘H]20:4 was very rapidly incorporated into diacyl glycerophosphocholine 
(GPC). After the removal of free 20:4, the radioactivity was gradually lost from diacyl GPC. 
Concomitantly, the radioactivities in alkylacyl GPC and alkenylacyl glycerophosphoethanolamine (GPE) 
were increased, indicating that 20:4 was mobilized from diacyl GPC to alkylacyl GPC and alkenylacyl 
GPE. The mobilization was considered to be a 20 :4-specific event. The gradual accumulation of 20 : 4 in 
ether phospholipids leads to a high abundance of 20:4 in these lipids. These results suggest metabolic 
relationships between 20:4 and ether phospholipids, including platelet-activating factor (PAF). 




In [l] we have demonstrated that high levels of 
alkylacyl GPC (32.5% of CGP) and alkenylacyl 
GPE (61.2% of EGP) are observed in rabbit 
alveolar macrophages. It seems a distinctive 
feature of various types of leukocytes such as 
macrophages [l-3], polymorphonuclear leuko- 
cytes [2,4] and lymphocytes [2,5], that they contain 
high amounts of alkylacyl GPC which are utilized 
for the synthesis of PAF by a deacylation-re- 
acetylation reaction [3]. 
Interestingly, ether phospholipids contain higher 
amounts of 20: 4 than diacyl analogue in these 
cells. About 73.6% of 20:4-containing species in 
Abbreviations: 20 : 4, arachidonic acid; 18 : 2, linoleic 
acid; CGP, choline glycerophospholipids; EGP, 
ethanolamine glycerophospholipids; IGP; inositol 
glycerophospholipids; GPC, glycerophosphocholine; 
GPE, glycerophosphoethanolamine; BSA, bovine serum 
albumin; Hepes, N-2-hydroxyethylpiperazine-N’-2- 
ethanesulfonic acid; PAF, platelet-activating factor 
CGP and 85.9% of those in EGP possess alkenyl 
or alkyl ether moieties at their l-positions in rabbit 
alveolar macrophages [l]. It will, therefore, be a 
very important problem to investigate precisely, 
the metabolism of 20: 4 both in ether 
phospholipids and diacyl phospholipids in order to 
gain a better understanding of the regulatory 
mechanism of 20 : 4 in these cells. Indeed, little is 
known about the biochemical nature of ether 
phospholipids in immunological competent cells. 
We here found that the mobilization of 20: 4 
from diacyl GPC to alkylacyl GPC and alkenylacyl 
GPE occurs in rabbit alveolar macrophages. This 
observation may be closely related to the high 
abundance of 20 : 4 in ether phospholipids. 
2. MATERIALS AND METHODS 
Alveolar macrophages were prepared from 
pulmonary lavage as in [l]. [5,6,8,9,11,12,14,15- 
3H] 20:4 (110 Ci/mmol) and [l-r4C]18:2 (55 
mCi/mmol) were purchased from Amersham. 
[3H]20: 4 was diluted with non-radioactive 20: 4 
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(final specific activity, 55 mCi/mmoI). Both 
[3H]20: 4 and [14C] 18 : 2 were purified by thin-layer 
chromatography (TLC) before use. Macrophages 
were suspended in 20 mM Hepes-Eagle’s minimal 
essential medium (MEM) (pH 7.2) at IO6 cells/ml; 
0.2 &i of labeled fatty acid, dissolved in 50 ~1 of 
0.2% bovine serum albumin (BSA)-containing 
saline, was added to 1 ml of the cell suspension and 
incubated at 37°C for 7.5 ([‘H]20:4) or 60 min 
([14C] 18 : 2). Then, the cells were cooled (4°C) and 
sedimented by centrifugation. After the removal of 
the medium, cells were washed 3 times with ice- 
cold (4°C) 0.2% BSA-containing 20 mM 
Hepes-MEM and resuspended in the same medium 
at lo6 cells/ml. Further incubation was carried out 
at 37°C and terminated by adding chloro- 
form : methanol (1: 2). 
Total lipids were extracted as in [6]. Individual 
phospholipids were separated by 2-dimensional 
TLC [I ,2]. A portion of the total lipids was also 
subjected to neutral lipid analysis by TLC, using 
the solvent, petroleum ether : ethyl ether :acetic 
acid (80: 20: 1). Alkenylacyl, alkylacyl and diacyl 
lipid classes of CGP and EGP were separated as 
1,2-diradyl-3-acetylglycerol derivatives, using the 
solvents, petroleum ether : ethyl ether : acetic acid 
(90: 10: 1) and then toluene as described in [ 1,2,5]. 
The lipid spots were scraped off from the plates in- 
to counting vials. The radioactivity was measured 
in a scintillation counter, using the toluene-Triton 
X-100 2:4, v/v) scintillation fluid, 
3. RESULTS AND DISCUSSION 
About 88.9% of the radioactivity of [3H]20:4 
incorporated into cells was found in the phospho- 
lipid fraction. The radioactivity of the total 
phospholipids and those among individual neutral 
lipids were not significantly changed after the 
removal of unincorporated labeled 20:4 (not 
shown). Table 1 shows the distribution of [3H]20:4 
amon individual phospholipids. At the zero time, 
the radioactivities were mainly distributed in CCP, 
EGP, inositol glycerophospholipids (IGP) and 
lyso-bis-phosphatidic acid and those in other 
phospholipids were only small. After the exchange 
of the medium, the radioactivity of CGP decreased 
with time. On the contrary, that of EGP increased 
gradually. A small increase was also observed for 
lyso-bis-phosphatidic acid and IGP. These redistri- 
butions of [3H]20:4 indicate that 20:4 once incor- 
porated into cells were then mobilized between 
these phospholipids. Authors in [7] demonstrated 
the CoA-mediated transfer of 20:4 from CGP to 
EGP in mouse lymphocytes and macrophages. Our 
results support this finding. In order to examine 
this point in more detail, we separated CGP and 
EGP into alkenylacyl, alkylacyl and diacyl classes 
which are known to be different from each other 
in various biochemical properties [S]. 
Fig.1 shows the distribution of [3H]20:4 in 
alkenylacyl, alkylacyl and diacyl GPC and GPE as 
a function of time after the exchange of the 
Table 1 
Percent distribution of t3H]20:4 among phospholipids after the removal of free t3H]20:4 
Phospholipids Time (mm) 
0 15 30 60 120 
Choline glycerophospholipids 61.5& 1.2 56.6kO.3 52.OkO.5 43.OkO.9 33.OkO.7 
Ethanolamine glycerophospholipids 10.3 + 0.5 13.5kO.3 15.9kO.3 20.5 * 0.4 27.2kO.5 
Inositol glycerophospholipids 11.3t0.3 12.2t0.7 12.8kO.7 14.4kO.7 13.9+ 1.0 
Lyso-bis-phosphatidic acid 15.0~0.3 16.0+0,9 16.9+0.3 19.9kO.3 23.1 eO.2 
Sphingomyelin 0.4kO.2 0.4*0.1 0.4+0.1 0.3 to.1 0.6kO.2 
Serine glycerophospholipids 1.2kO.l 1.1 so.7 1X+0.6 1*5+0.2 1.920.4 
Cardiolipin 0.1 +o.o 0.110.0 0.1 io.0 0.2+0.1 0.2%0.1 
Phosphatidic acid 0.2LO.l 0.1 kO.1 0.1 kO.0 0.220.1 0.1 t-o.1 
Macrophages were prelabeled with [3H]20:4 (0.2&i) for 7.5 min. Then the cells were washed 3 times with 0.2% BSA- 
containing Eagle’s MEM and further incubated at 37°C in the same medium. Individual phospholipids were separated 
by 2-dimensional TLC as described in the text. The values represent he means + SD taken from 3 determinations 
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Fig.1. The radioactivities of [3H]20:4 in alkenylacyl, 
-+ SD. 
alkylacyl and diacyl GPC (a) and GPE (b) after the 
removal of free [3H]20:4. Alkenyla~yl (A), alkylacyl (0) 
and diacyl (0) lipid classes were separated as described 
in the text. Each point is the mean of 3 determinations 
medium. Diacyl GPC was most rapidly labeled 
with t3H]20:4 after 7.5 min incorporation. 
However, the radioactivity was lost from this lipid 
class soon after the removal of free 20:4, in- 
dicating that the turnover of 20:4 is very rapid in 
diacyl GPC. In contrast, the radioactivities of 
alkylacyl GPC and alkenylacyl GPE were marked- 
ly increased during the incubation. The radioac- 
tivity of diacyl GPE was, however, almost unaf- 
fected. Although the radioactivities of alkenylacyl 
GPC and alkylacyl GPE were also increased to 
some extent, these were very low compared with 
the radioactivities in other lipid classes. Therefore, 
it can be considered that 20:4 was mainly transfer- 
red from diacyl GPC to alkylacyl GPC and 
alkenylacyl GPE. This may be closely related to 
the fact that both alkylacyl GPC and alkenylacyl 
GPE contain high amounts of 20:4 in rabbit 
alveolar macrophages [I]. It is very likely that 
ether phospholipids act as the storage of 20:4. In- 
deed, it has already been reported that 20:4 was re- 
tained in ether phospholipids in rat testes during 
the essential fatty acid deficiency 191. 
We did not find any marked change of the 
radioactivity for 20:4 (fig.2). This suggests that the 
mobilization is a 20:4-specific phenomenon. Some 
years ago, it was shown [lo] that 20:4 is mobilized 
from CGP or IGP to alkenylacyl GPE in 
thrombin-treated platelets. Our present result is 
compatible with their observation. We also 
detected the selective mobilization of 20:4 from 
diacvl GPC to alkylacyl GPC. This leads to high 
levels of alkyl-arachidonyl GPC (12.5% of CGP) 
0 15 30 60 120 mm 
Fig.2. The radioactivities of ]r4C]18:2 in alkenylacyl, 
alkylacyl and diacyl GPC (a) and GPE (b) after the 
removal of free [r4C]18:2. Alkenylacyl (A), alkylacyl 
minations + SD. 
(*I and diacyl (0) lipid classes were separated as 
described in the text. Each point is the mean of 3 deter- 
in rabbit alveolar macrophages [I]. The selective 
acyIation of alkyl GPC with 20:4 has been also 
demonstrated in human neutrophils [ 111. It is very 
noticeable that both alkyl GPC and 20:4 can act as 
the substrates for the potent lipid mediators, PAF 
or prostaglandins (PGs), thromboxanes (TXs) and 
leukotrienes (LTs). The biosynthesis of these lipid 
mediators might be, therefore, a coupled event. 
The transesterification rate of 20:4 to alkyl GPC 
(lyso PAF) or alkenyl GPE might affect their 
availabilities for lipid mediator synthesis. Further- 
more, the modes of actions of these lipids may be 
closely related to each other. In fact it has been 
shown that 20:4 metabolite, $L-hydroxyeicosa- 
tetraenoic acid (5L-HETE) potentiates the 
degranulating action of PAF in human neutrophiis 
[12]. However, it remains to be determined which 
lipid class is most responsible for 20:4 generation 
for the synthesis of cyclooxygenase or lipox- 
ygenase products under stimulated conditions. 
It is possible that acyltransferase is involved in 
the transesterification of 20:4 as pointed out in [7]. 
The acyltransferase activities to alkenyl GPE 
[13-151 and to alkyl GPC [14-161 have been 
already demonstrated using the microsomes from 
severa tissues. Although their activities are shown 
to be considerably lower in comparison with those 
to I-acyl compounds, they are highly specific for 
unsaturated fatty acids including both 20:4 and 
18:2 [14,16,17]. Further studies are necessary to 
clarify the mechanism and the significance of the 
selective mobilization of 20:4 between diacyl and 
ether-containing phospholipids. 
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